Results 171 to 180 of about 1,293,045 (377)
Coronary Heart Disease: Angina Pectoris: Myocardial Infarction [PDF]
openalex +2 more sources
Cancer and coronary artery disease among seventh-day adventists
Ernest L. Wynder+2 more
openalex +1 more source
This study have loaded chiral gold nanoclusters onto the inner and outer surfaces of ZIF and uncovers the biodistribution, metabolic variances, and therapeutic mechanism of chiral nanoparticles, providing deep insights into the nanobiological effects of chiral anti‐inflammatory nanomedicines in PD therapy for future clinical transformation.
Junyang Chen+7 more
wiley +1 more source
Background Inflammation is a key driver of atherosclerotic diseases and is often accompanied by disease-related malnutrition. However, the long-term burden of dysregulated inflammation with superimposed undernutrition in patients with acute coronary ...
Yang Yuxiu+5 more
doaj +1 more source
A Multi-physics Model of Flow from Coronary Angiography: Insights into Microvascular Function [PDF]
Coronary Artery Disease (CAD) and Coronary Microvascular Disease (CMD) can lead to insufficient blood flow to the myocardium, affecting millions of people globally. Coronary angiography, one of the most commonly used imaging modalities, offers valuable information that assists in diagnosing these diseases.
arxiv
Sickness Absence before the First Clinical Episode of Coronary Heart Disease
J. A. Heady+3 more
openalex +1 more source
UNDERNUTRITION IN THE TREATMENT OF CORONARY ARTERY DISEASE (PARTICULARLY THROMBOSIS). EFFECT ON THE BASAL METABOLISM AND CIRCULATION 1 [PDF]
Arthur M. Mastér+2 more
openalex +1 more source
Novel Electroactive Therapeutic Platforms for Cardiac Arrhythmia Management
Electroactive platforms offer promising applications in cardiac arrhythmia. Based on their energy sources and mechanisms, electroactive platforms are categorized into i) direct electrical stimulation, ii) self‐powered electroactive systems, iii) physical stimuli‐mediated electroactive systems, and iv) conductive systems, and their applications in ...
Juwei Yang+4 more
wiley +1 more source
Dipyridamole Acts as Clinical Ferroptosis Inhibitor to Prevent from Tissue Injury
Dipyridamole acts as a clinically used compound to suppress ferroptosis. Dipyridamole down‐regulates the expression of RNF126, which is an E3 ligase to ubiquitinate SLC7A11 for proteasome degradation. The deficiency of SLC7A11 largely abolishes the protective role of dipyridamole both in vitro and in vivo.
Xiao Zhuang+22 more
wiley +1 more source
Postoperative cardiac adhesions lead to numerous difficulties in reoperation procedures. Here, a thermo‐responsive in situ formed hydrogel is shown to can reliably cover the wounds after a convenient spraying or injection and significantly reduce adhesion formation in primary and recurrent cardiac injury adhesion models.
Kun Shi+11 more
wiley +1 more source